【レポートの概要（一部）】
※レポート紹介PDF⇒ http://www.vaczine-analytics.com/VAMV033_TOC_150302.pdf
****This product is composed of two models and summary presentation
Author’s note
Contents
Executive Summary
Commercial model: outputs
General summary of changes from versions 2013 to 2015
HBV vaccines: revenues by vaccine type to 2030 (Western) ($m)
HBV vaccines: revenues by vaccine type to 2030 (per country) ($m)
Monovalent HBV vaccines: revenues to 2030 (per country) ($m)
Monovalent HBV vaccines: revenues to 2030 (per risk group) ($m)
Heplisav: market revenues to 2030 ($m) – SCENARIO 1
Heplisav: market revenues to 2030 ($m) – SCENARIO 2
Hepatitis B virus background: Epidemiology update
HBV: epidemiology summary
HBV: global epidemiology
HBV: global prevalence of chronic infection
Characteristics of hepatitis B in US
US: HBV incident cases and risk exposures (2012)
Reported number of acute HBV cases – US, 2000-2012
US: HBV incident cases and risk exposures 1980-2010
Acute HBV reports by risk exposure (US, 2012)
US – HBV surface antigen positivity by state, 2009
Europe: HBV epidemiology
Europe: number of reported HBV cases in the EU/EEA, 2012
Number and rates of HBV reported cases, EU/EEA, 2009-2012
Europe: HBV cases – by age group & gender EU/EEA (2011)
Hepatitis B virus background: vaccines
Reimbursement polices: per major risk group/country
Vaccine market share split per country
At risk populations per country
HBV vaccine coverage by country
HBV background
HBV epidemiology summary
HBV global epidemiology
US: incident cases and risk exposures
National HBV vaccine policies
National HBV vaccine policies: forecast immunity to 2030
Hepatitis B vaccines: major suppliers
Hepatitis B vaccines: dosing/administration schedules
GSK Biologicals: hepatitis vaccine sales, 2005-14
Merck & Co (SPMSD): hepatitis vaccine sales, 2005-14
Engerix B: SWOT
Recombivax-HB: SWOT
New Hepatitis B vaccines: Heplisav (Dynavax)
Dynavax: Heplisav – background
Heplisav: Phase III data
Heplisav: seroprotection rates (HBV-16) study
Heplisav: immunogenicity in diabetic subjects
Heplisav: FDA – Complete Response Letter
Heplisav: HBV-23 study
Heplisav: approval timeframe (US)
HBV vaccines: commercial model: key assumptions and methodology
Overview of modeling strategy
Target populations modelled
HBV vaccines: target populations (US, 2015) (000s)
Healthcare workers: modeling strategy
Travelers: modeling strategy
Diabetics: modeling strategy, US
Infants: modeling strategy
Other “at risk” populations: modelling strategy
Summary of population changes from version 2013 – 2015
Pricing and reimbursement
Pricing assumptions
Market share split by country: by vaccine type
At risk populations by country
HBV vaccine coverage by country
HBV vaccination in US diabetics 2010-2013
Heplisav: market share/pricing estimates
Heplisav: expected commercial value US
Appendix I: Actual reported and estimated sales data
Hepatitis vaccines sales data
Bibliography
About VacZine Analytics
Disclaimer
*** PAGES: ~74 MS PowerPoint slides, fully referenced/sourced. Available in .pdf form
【レポート販売概要】
■ タイトル：B型肝炎ワクチンの世界市場機会分析■ 英文：MarketVIEW: Hepatitis B virus vaccines - Global vaccine commercial opportunity assessment
■ 発行日：2015年3月
■ 調査会社：VacZine Analytics
■ 商品コード：MR-VAMV033
■ 調査対象地域：グローバル
- 酵母成分の世界市場：酵母エキス、自己消化酵母、酵母細胞壁、酵母フレーバーYeast ingredients are rich blends of natural components with significant taste and an influencing nutritional profile. These ingredients have prolific applicability in food, feed, pharmaceutical, personal care, and cosmetics industries. Yeast ingredients possess unique characteristics to reduce salt and fat contents in processed food products and are a competent substitute for MSG. Keeping in view …
- 企業向けストレージシステムの世界市場2016-2020：SAN、NAS、DASAbout Enterprise StorageAn enterprise storage system is a repository for business information or data for a period of time depending on end-user requirements. Enterprise users can access these data and share them through interconnected networks or online. Enterprise storage comprises SSD and hard disk drives (HDD) devices that are commonly used in SAN, NAS, and DAS environments. The data stored ca …
- Machine-to-Machine (M2M) and Radio Frequency ID (RFID) Second EditionMachine-to-Machine (M2M) communications and Radio Frequency ID (RFID) together represent a means of direct communication between connection hardware and the object that needs monitoring: the information about its status of performance is directly sent to a computer system without the need for human intervention. This makes automation of processes or consumer action possible. The technology that ut …
- Mid-Cap Biotechnology社のベンチマークレポート：販売予測、製品分析PharmaLeaders: Mid-Cap Biotechnology Benchmark Report - Sales Forecasts and Product Valuations of Innovative Biotechs Summary GlobalData’s "PharmaLeaders: Mid-Cap Biotechnology Benchmark Report - Sales Forecasts and Product Valuations of Innovative Biotechs" applies our proprietary ranking methodology to compare the competitive positions of 35 mid-cap biotechnology companies on 14 financial metric …
- ドイツの滅菌器市場見通し（～2021）Germany Sterilization Equipment Market Outlook to 2021 Summary GlobalData’s new report, "Germany Sterilization Equipment Market Outlook to 2021", provides key market data on the Germany Sterilization Equipment market. The report provides value, in millions of US dollars, volume (in units) and average price data (in US dollars), within market segments - Chemical Sterilizers, Physical Sterilizers an …
- 自動車用排ガス熱回収（EGHR）システムの世界市場2018-2022About automotive exhaust gas heat recovery system (EGHR) An automotive exhaust gas heat recovery system (EGHR) is located in the exhaust system of the vehicle. This compact unit recovers heat from the vehicle exhaust and utilizes the heat to warm the engine fuels and the cabin. Technavio’s analysts forecast the Global automotive exhaust gas heat recovery system (EGHR) market to grow at a CAGR of 4 …
- 心臓再同期療法（CRT）デバイスの世界市場：CRT-D、CRT-PAbout Cardiac Resynchronization Therapy Devices According to the WHO, cardiovascular disease is one of the leading cause of death worldwide. It is estimated that around 17.5 million people died from cardiovascular disease, which accounted for 31% of all global deaths in 2012. Cardiovascular disease can be prevented by addressing behavioral risks such as obesity, cigarette smoking, and an unhealthy …
- Phillips 66 Company：石油・ガスバリューチェーン分析レポート2013Phillips 66 Company Analysis Across the Oil and Gas Value Chain Report, 2013 Update Summary "Phillips 66 Company" Analysis Across the Oil and Gas Value Chain is an essential source for data, analysis and strategic insight into “Phillips 66 Company”. The report provides key information relating to oil and gas assets of the company along with its operations across the value chain. The report examine …
- 世界の殺線虫剤市場2015The Global Nematicides Industry Report 2015 is a professional and in-depth study on the current state of the Nematicides industry. The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure.The Nematicides market analysis is provided for the international markets including development trends, competitive landscape analysis …
- 重工業向けロボットの世界市場：マテリアルハンドリングロボット、組み立てラインロボット、溶接ロボットAbout Industrial Robotics Market in Heavy Industries Industrial robotics refers to the use of robots in the manufacturing and assembly processes in the automotive, heavy industries, and electronics industries. Industrial robots are programmed to automate and control manufacturing processes such as welding, painting, assembly, product inspection, testing, and packaging. There are several types of i …
- 世界のアプタマー（Aptamer）市場：治療、診断、バイオセンサー用途などAptamers is an emerging market, widely considered as a rival or substitute to antibodies in the scientific industry. It is poised to grow rapidly in various application areas, including therapeutics and diagnostics. The global aptamers market is valued at $287 million in 2013 and is expected to reach $2.1 billion by 2018. Aptamers existed in parallel with antibodies for two decades, but its market …
- 抗CD20モノクローナル抗体（mAb）の世界市場2019-2023Global Anti-CD20 Monoclonal Antibodies (mABs) Market: About this market Technavio’s anti-CD20 monoclonal antibodies (mABs) market analysis considers sales from oncology, neurology, and immunology. Our analysis also considers the sales of anti-CD20 monoclonal antibodies (mABs) in Asia, Europe, North America, and ROW. In 2018, the oncology segment had a significant market share, and this trend is ex …
- 世界における胸の画像検査技術（マモグラフィー、PET/CT、超音波等）市場The global breast imaging technologies market is estimated to grow at a CAGR of 8.1% from 2014 to 2019. Although the mature markets (such as the U.S., Germany, and the U.K.) hold larger shares in the breast imaging technologies market, the Asia-Pacific region is expected to grow at the highest CAGR of 10.2% in the forecast period. The growth of the breast imaging technologies market is driven by f …
- 2014年戦略提言：世界の治療薬物モニタリング(TDM)市場Complete report $8,500. DataPack (test volumes, sales forecasts, supplier shares) $5,500.This new 313-page report from Venture Planning Group contains 83 tables and provides analysis of the global therapeutic drug monitoring testing market, including emerging tests, technologies, instrumentation, sales forecasts by country, market shares, and strategic profiles of leading suppliers. Th …
- 世界の熱処理式空気清浄機市場動向（2012-2016）TechNavio's analysts forecast the Global Thermal Treatment Air Filtration market to grow at a CAGR of 7.55 percent over the period 2012-2016. One of the key factors contributing to this market growth is the increasing demand from the process industries. The Global Thermal Treatment Air Filtration market has also been witnessing the increasing demand for end-to-end service. However, the increasing …
